These effects may potentially provide a novel therapeutic solution for stroke, imparting specific beneficial effects on the CNS (i.e., for reperfusion, the amelioration of neuronal damage and, thereby, recovery without memory, locomotor, and coordination disturbances, and the expression of the particular genes in the hippocampus)
01 Modulates 4,000+ genes (6% 02 70% improvement in skin 03 35% increase in procollagen Anti-Aging & Longevity GHK-Cu is a naturally occurring copper-binding tripeptide that declines with age
But what exactly are they
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
KLOW adds two additional peptides: GHK-Cu (a copper peptide that rebuilds collagen and supports skin quality) and KPV (an anti-inflammatory peptide with specific gut-healing properties)
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
